文献速递胸部CT

亚毫西弗低剂量CT联合深度学习图像重建评估肺部亚实性结节的可行性

Feasibility of Sub-milliSievert Low-dose Computed Tomography with Deep Learning Image Reconstruction in Evaluating Pulmonary Subsolid Nodules: A Prospective Intra-individual Comparison Study.
PubMed 文献 · Acad Radiol · 2024-12-13

前瞻性纳入102例患者358个亚实性结节,比较标准剂量CT与低剂量CT(DLIR-H、DLIR-M、ASIR-V-50%、FBP)的图像质量和结节检出。低剂量CT有效剂量0.86 mSv,DLIR-H噪声最低、CNR/SNR最高,检出率76.5%,形态特征检出率79.4%-95.2%。

要点

  • DLIR-H在亚毫西弗低剂量下图像质量接近标准剂量CT,可显著降低辐射剂量。
  • DLIR-H对亚实性结节检出率76.5%,形态特征检出率79.4%-95.2%,优于其他低剂量重建。
  • ASIR-V-50%检出率最高(83.8%)但假阳性率也最高(8.3%),需注意假阳性。

关键影像表现/征象

  • DLIR-H在低剂量组中噪声最低,CNR和SNR最高,主观评分最高(均P<0.001),接近标准剂量CT。
  • DLIR-H对形态特征检出率79.4%-95.2%,高于DLIR-M(74.6%-88.9%)、ASIR-V-50%(72.0%-88.4%)和FBP(66.1%-84.1%)(均P≤0.001)。

诊断标准与关键数值

  • 标准剂量CT和低剂量CT平均有效剂量分别为5.37±0.80 mSv和0.86±0.14 mSv(P<0.001)。
  • 亚实性结节检出率:DLIR-H 76.5%、DLIR-M 76.3%、ASIR-V-50% 83.8%、FBP 72.1%(P<0.001)。
  • 假阳性率:DLIR-H 2.5%、DLIR-M 2.2%、ASIR-V-50% 8.3%、FBP 1.1%(P<0.001)。

临床应用与阅片要点

  • 在亚毫西弗低剂量筛查中优先选用DLIR-H重建,以兼顾图像质量和结节检出。
  • ASIR-V-50%检出率虽高但假阳性率也高,报告时需结合形态特征谨慎判断。
  • 评估亚实性结节形态特征时,DLIR-H较其他低剂量重建更可靠。

局限性

  • 单中心前瞻性研究,样本量有限。
  • 参考标准为标准剂量CT而非病理,可能存在参考偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: To comprehensively assess the feasibility of low-dose computed tomography (LDCT) using deep learning image reconstruction (DLIR) for evaluating pulmonary subsolid nodules, which are challenging due to their susceptibility to noise.

MATERIALS AND METHODS: Patients undergoing both standard-dose CT (SDCT) and LDCT between March and June 2023 were prospectively enrolled. LDCT images were reconstructed with high-strength DLIR (DLIR-H), medium-strength DLIR (DLIR-M), adaptive statistical iterative reconstruction-V level 50% (ASIR-V-50%), and filtered back projection (FBP); SDCT with FBP as the reference standard. Objective assessment, including image noise, contrast-to-noise ratio (CNR), and signal-to-noise ratio (SNR), and subjective assessment using five-point scales by five radiologists were performed. Detection and false-positive rate of subsolid nodules, and morphologic features of nodules were recorded.

RESULTS: 102 patients (mean age, 57.0 ± 12.3 years) with 358 subsolid nodules in SDCT were enrolled. The mean effective dose of SDCT and LDCT were 5.37 ± 0.80mSv and 0.86 ± 0.14mSv, respectively (P < 0.001). DLIR-H showed the lowest noise, highest CNRs, SNRs, and subjective scores among LDCT groups (all P < 0.001), almost approaching comparability with SDCT. The detection rates for DLIR-H, DLIR-M, ASIR-V-50%, and FBP were 76.5%, 76.3%, 83.8%, and 72.1%, respectively (P < 0.001), with false-positive rate of 2.5%, 2.2%, 8.3%, and 1.1%, respectively (P < 0.001). DLIR-H showed the highest detection rates for morphologic features (79.4%-95.2%) compared to DLIR-M (74.6%-88.9%), ASIR-V-50% (72.0%-88.4%), and FBP (66.1%-84.1%) (all P ≤ 0.001).

CONCLUSION: Sub-milliSievert LDCT with DLIR-H offers substantial dose reduction without compromising image quality. It is promising for evaluating subsolid nodules with a high detection rate and better identification of morphologic features.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Zhu H, Huang Z, Chen Q, et al. Feasibility of Sub-milliSievert Low-dose Computed Tomography with Deep Learning Image Reconstruction in Evaluating Pulmonary Subsolid Nodules: A Prospective Intra-individual Comparison Study. Acad Radiol. 2024. PMID: 39674695. doi:10.1016/j.acra.2024.11.042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。